MindMed Announces $25 Million Bought Deal Public Offering

NEW YORK, Nov. 25, 2020 /CNW/ – Mind Medicine (MindMed) Inc. (NEO: MMED) (OTCQB: MMEDF) (“MindMed” or the…

MindMed to Launch Albert, A Digital Medicine Division for Psychedelic Medicines

NEW YORK, Nov. 24, 2020 /CNW/ — MindMed (NEO: MMED) (OTCQB: MMEDF) (DE: MMQ), a leading psychedelic medicine…

MindMed Receives Approval of Protocol Design to Evaluate Microdoses of LSD For Adult ADHD In Phase 2a Clinical Trial from Swiss and Dutch Health Authorities

Mon, November 16, 2020, 7:30 AM GMT-5 Project Lucy Submits Pre-IND Briefing Package to the FDA;…

MindMed Announces the Completion of Phase 1 Study Measuring Dosing Effects of LSD

NEW YORK, Nov. 2, 2020 /PRNewswire/ — MindMed (NEO: MMED,OTCQB: MMEDF), the leading psychedelic medicine biotech company…

MindMed Closes Upsized Financing of CAD $28.75m With Strong Institutional Demand for Psychedelic Medicines

Post-Financing Cash Reserves of CAD $50.1m (USD $37.8m) to Enable Continued Advancement of Diverse and Growing Clinical Trial Pipeline…

Psychedelic highlights | October 05 – 09

Psychedelic highlights | October 05 – 09 1. M2Bio Sciences, Inc | WUHN  Announce a new Chief…

MindMed Announces $25 Million Bought Deal Public Offering at a price of C$1.05 per Unit

NEW YORK, Oct. 9, 2020 /CNW/ – Mind Medicine (MindMed) Inc. (NEO: MMED) (OTCQB: MMEDF) (“MindMed” or the…

Mind Cure Welcomes Dr. Jason Wallach to Scientific Advisory Board

Known globally for his industry research and expertise, Dr. Wallach will help to drive new areas…

MindMed Partners with NYU Langone Medical Center to Launch Groundbreaking Training Program for Psychedelic Therapies and Medicines

MindMed To Provide Funding for Psychedelic Medicine Research Training Program at NYU Langone Health and NYU…

Psychedelic highlights | September 21 – 25

Psychedelic highlights | September 21 – 25 1. COMPASS Pathways | CMPS can’t be stopped and…

MindMed and Liechti Lab Announce R&D Collaboration On Psilocybin

BASEL, Switzerland, Sept. 24, 2020 /PRNewswire/ — Mind Medicine (MindMed) Inc. (NEO: MMED)(OTC: MMEDF), the leading…

MindMed Submits Application For NASDAQ Up-Listing, Appoints Canaccord Genuity As Financial Advisor

NEW YORK, Sept. 21, 2020 /PRNewswire/ — Mind Medicine (MindMed) Inc. (NEO: MMED)(OTCQB: MMEDF)(DE: MMQ), the leading…